# Limited-Time $5,000 Minimum Investment Opportunity Through Sunday Night | Sen-Jam Pharmaceutical

- Canonical URL: https://wefunder.com/feed/350343
- Entity ID: wefunder:feed_item:350343
- Published at: 2026-07-10 01:39:37 UTC
- Updated at: 2026-07-10 11:48:05 UTC

## Author
Jim Iversen

## Subject
Sen-Jam Pharmaceutical

## Content
Dear Sen-Jam Community,We are getting close to an important near-term milestone.Sen-Jam is working toward a $250,000 goal in this current round, and we are now only $45,000 away from reaching it. Achieving this level would help unlock a dedicated Wefunder email outreach to accredited investors, giving us the opportunity to broaden awareness and momentum around the work we are building.To help close this gap, we are opening a special, limited-time opportunity through Sunday night, July 12, at 11:59 p.m. ET.For this period, we are lowering the minimum investment to $5,000. A $5,000 investment will also be eligible for a 6.5% common share bonus and a place on our cap table.→ You can view the private offering using this Wefunder link→ Schedule a call with me: calendly.com/jiversenThis means that just nine additional $5,000 investments would allow us to reach the $250,000 goal, while the published investor perks remain in place for larger investments. Sen-Jam has built more than a pipeline. We have built a belief: that helping the body resolve inflammation and return to balance is critical to helping people live longer, healthier, more resilient lives. That belief now guides our science, our platform, our partnerships, our investor conversations, and the evolution of Galaxy.We are grateful for the continued support of our investors, many of whom have increased their investment as Sen-Jam continues to execute. Their conviction reflects what we believe is becoming increasingly clear: Sen-Jam is not just advancing individual therapeutic assets — we are building an inflammatory resolution platform with the potential to create meaningful impact across recovery, prevention, chronic disease, addiction medicine, metabolic health, and longevity.Thank you for standing with us as we continue building toward this next stage.With gratitude,JimForward-looking statements: This update contains forward-looking statements regarding planned milestones, regulatory interactions, partnerships, valuation, and timing. These statements reflect current expectations and involve risks and uncertainties; actual outcomes, dates, and valuations may differ materially. Nothing in this communication is a guarantee of future results, valuation, or investment performance. This communication is intended for accredited investors and should be read together with the official offering materials.